Troponin elevation in conditions other than acute coronary syndromes
1Gazi University Faculty of Medicine, Department of Cardiology, Ankara, Turkey. aslitanindi@gmail.com
Insights
Cardiac troponin elevation indicates myocardial injury but not always acute coronary syndromes. This review explores non-acute coronary syndrome causes of troponin elevation, aiding differential diagnosis in emergency settings.
Area of Science:
- Cardiology
- Biomarkers
- Emergency Medicine
Background:
- Acute coronary syndromes (ACS) present with chest pain, but diagnosis is challenging due to varied patient presentations.
- Cardiac troponins are key biomarkers for myocardial infarction (MI) diagnosis and management.
- Troponin elevation signifies myocardial injury but doesn't specify the cause, necessitating differential diagnosis.
Purpose of the Study:
- To review conditions causing troponin elevation beyond acute coronary syndromes.
- To enhance physician understanding of the pathophysiology behind elevated troponins from various causes.
- To support accurate differential diagnosis in emergency medicine.
Main Methods:
- Literature review focusing on non-ACS causes of troponin elevation.
- Analysis of clinical conditions and pathophysiological mechanisms leading to myocardial injury.
- Synthesis of diagnostic challenges and strategies for interpreting troponin levels.
Main Results:
- Troponin elevation can occur in numerous conditions unrelated to ACS, including sepsis, pulmonary embolism, and heart failure.
- Understanding the diverse etiologies of troponin elevation is crucial for appropriate patient management.
- Differential diagnosis requires considering clinical context alongside biomarker levels.
Conclusions:
- Elevated cardiac troponins are not pathognomonic for acute coronary syndromes.
- Physicians must consider a broad differential diagnosis for troponin elevation.
- Accurate interpretation of troponin levels relies on understanding underlying pathophysiological mechanisms.
Abstract:
Acute coronary syndromes comprise a large spectrum of clinical conditions ranging from unstable angina pectoris to acute ST-elevation myocardial infarction. Chest pain is usually the major symptom of atherosclerotic heart disease; however, it may be challenging to diagnose correctly, especially in the emergency department, because of the ambiguous way that pain is characterized by some patients. Cardiac troponins are sensitive and specific biomarkers used in the diagnosis of myocardial infarction that are released into the bloodstream when cardiac myocytes are damaged by acute ischemia or any other mechanism. They are the cornerstone for the diagnosis, risk assessment, prognosis, and determination of antithrombotic and revascularization strategies. However, troponin elevation indicates the presence, not the mechanism, of myocardial injury. There are many clinical conditions other than myocardial infarction that cause troponin elevation; thus, the physician should be aware of the wide spectrum of disease states that may result in troponin elevation and have a clear understanding of the related pathophysiology to effectively make a differential diagnosis. This review focuses on causes of troponin elevation other than acute coronary syndromes.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Hypertension III: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome V: Nursing Management

